Singapore markets closed

ARS Pharmaceuticals, Inc. (SPRY)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
9.96-0.04 (-0.40%)
At close: 04:00PM EDT
10.33 +0.37 (+3.71%)
After hours: 07:56PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts3333
Avg. Estimate-0.15-0.16-0.69-0.34
Low estimate-0.22-0.22-0.85-0.6
High estimate-0.08-0.09-0.570.03
Year ago EPS-0.16-0.18-0.57-0.69
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts2233
Avg. EstimateN/AN/A5.54M85.45M
Low estimateN/AN/A2.68M55.36M
High estimateN/AN/A8M137M
Year ago salesN/A10k30k5.54M
Sales growth (year/est)N/AN/A18,366.70%1,442.40%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.17-0.17-0.18-0.14
Actual EPS-0.16-0.18-0.16-0.07
Difference0.01-0.010.020.07
Surprise %5.90%-5.90%11.10%50.00%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.15-0.16-0.69-0.34
7 days ago-0.17-0.18-0.75-0.53
30 days ago-0.16-0.17-0.73-0.58
60 days ago-0.18-0.18-0.74-0.7
90 days ago-0.18-0.18-0.74-0.7
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 days1111
Up last 30 days1112
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesSPRYIndustrySector(s)S&P 500
Current qtr.6.30%N/AN/AN/A
Next qtr.11.10%N/AN/AN/A
Current year-21.10%N/AN/AN/A
Next year50.70%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A